Sign in Pull a receipt

JBIO

Jade Biosciences, Inc.

Healthcare · Biotechnology

$84.92 sample

+0.19 (+0.22%) 1D

Market cap

$534.6B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-13

Alerts

8

Price$84.92 +3.98% 3M daily closessample

86.4180.46

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: EVP, Operations
Oct 16INSInsider buy: Director
Oct 13SECDEF 14A filed
Oct 08INSInsider sell: Director
Oct 02INSInsider sell: General Counsel
Sep 29INSInsider buy: Director
Sep 22INSInsider sell: 10% owner
Sep 16INSInsider sell: Chief Financial Officer

Sign up to see the real JBIO record →

Company facts

SEC EDGAR registration

Name: Jade Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +5sample, -100 to +100
Reporting currency: USD

Who is positioning in JBIO

sample

Insiders: 26 insider transactions over 90 days, net selling, $743.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 17 funds hold $9.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.3B +13.0% y/y

Q4 2024Q3 2026

Inventory$11.3B +19.9% y/y

Q4 2024Q3 2026

Accounts receivable$8.4B +10.1% y/y

Q4 2024Q3 2026

Total debt$21.4B +5.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $143.6B -3.5% 3M
Sample peer B: $266.6B +6.4% 3M
Sample peer C: $102.8B -10.6% 3M
Sample peer D: $263.5B -0.6% 3M
Sample peer E: $413.2B +10.9% 3M